Neutralization of Bothrops asper venom by antibodies, natural products and synthetic drugs: Contributions to understanding snakebite envenomings and their treatment

Toxicon

Volumn 54, Issue 7, 2009, Pages 1012-1028

  Lomonte, Bruno ^a   León, Guillermo ^a   Angulo, Yamileth ^a   Rucavado, Alexandra ^a   Núñez, Vitelbina ^b  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Antibodies; Antivenoms; Inhibitors; Natural products; Neutralization; Snake; Venom

Indexed keywords

BATIMASTAT; BIXA ORELLANA EXTRACT; CASEARIA SYLVESTRIS EXTRACT; CLODRONIC ACID; DOXYCYCLINE; EDUNOL; FLAVONOID; FUCOIDIN; HEPARIN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; NATURAL PRODUCT; NEUTRALIZING ANTIBODY; PERSEA AMERICANA EXTRACT; PHOSPHOLIPASE A2; PIMENTA DIOICA EXTRACT; PIPER PELTATUM EXTRACT; PIPER UMBELLATUM EXTRACT; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PTEROCARPAN; SAPONIN DERIVATIVE; SNAKE VENOM; SNAKE VENOM ANTISERUM; SURAMIN; TRITERPENOID; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANALGESIC ACTIVITY; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AVOCADO; BIXA ORELLANA; BLOOD CLOTTING; CASEARIA SYLVESTRIS; CLINICAL TRIAL; DRUG DISTRIBUTION; DRUG HALF LIFE; ENVENOMATION; EXPERIMENTAL STUDY; HUMAN; MEDICINAL PLANT; MOLECULAR MECHANICS; NONHUMAN; PIMENTA DIOICA; PIPER PELTATUM; PIPER UMBELLATUM; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SNAKEBITE; VASCULAR DISEASE;

ANIMALS; ANTIBODIES; BIOLOGICAL PRODUCTS; BOTHROPS; CROTALID VENOMS; HUMANS; SNAKE BITES;

ANIMALIA; BOTHROPS ASPER;

EID: 70249088378     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2009.03.015     Document Type: Article

References (209)

1. Abalos J.W. The ophiofagus habits of Pseudoboa cloelia. Toxicon 1 (1963) 90
2. Alape-Girón A., Sanz L., Escolano J., Flores-Díaz M., Madrigal M., Sasa M., and Calvete J.J. Snake venomics of the lancehead pitviper Bothrops asper: geographic, individual, and ontogenic variations. J. Proteome Res. 7 (2008) 3556-3571
3. Anderson S.G., Gutiérrez J.M., and Ownby C.L. Comparison of the immunogenicity and antigenic composition of ten Central American snake venoms. Toxicon 31 (1993) 1051-1059
4. 2. Biochem. Pharmacol 66 (2003) 1993-2000
5. Angulo Y., Estrada R., and Gutiérrez J.M. Clinical and laboratory alterations in horses during immunization with snake venoms for the production of polyvalent (Crotalinae) antivenom. Toxicon 35 (1997) 81-90
6. Aragón F., and Gubenšek F. Bothrops asper venom from the Atlantic and Pacific zones of Costa Rica. Toxicon 19 (1981) 797-805
7. Araujo H.P., Bourguignon S.C., Boller M.A.A., Dias A.A.S.O., Lucas E.P.R., Santos I.C., and Delgado I.F. Potency evaluation of antivenoms in Brazil: the national laboratory experience between 2000 and 2006. Toxicon 51 (2008) 502-514
8. Arce V., Rojas E., Ownby C.L., Rojas G., and Gutiérrez J.M. Preclinical assessment of the ability of polyvalent (Crotalinae) and anticoral (Elapidae) antivenoms produced in Costa Rica to neutralize the venoms of North American snakes. Toxicon 41 (2003) 851-860
9. Arce-Estrada V., Azofeifa-Cordero G., Estrada R., Alape-Girón A., and Flores-Díaz M. Neutralization of venom-induced hemorrhage by equine antibodies raised by immunization with a plasmid encoding a novel P-II metalloproteinase from the lancehead pitviper Bothrops asper. Vaccine 27 (2009) 460-466
10. Arroyo O., Rojas G., and Gutiérrez J.M. Envenenamiento por mordedura de serpiente en Costa Rica en 1996: epidemiología y consideraciones clínicas. Acta Médica Costarricense 41 (1999) 23-29
11. Arruda E.Z., Silva N.M., Moraes R.A., and Melo P.A. Effect of suramin on myotoxicity of some crotalid snake venoms. Braz. J. Med. Biol. Res. 35 (2002) 723-726
12. Azofeifa K., Angulo Y., and Lomonte B. Ability of fucoidan to prevent muscle necrosis induced by snake venom myotoxins: comparison of high- and low-molecular weight fractions. Toxicon 51 (2008) 373-380
13. Barrantes A., Solís V., and Bolaños R. Alteración de los mecanismos de la coagulación en el envenenamiento por Bothrops asper (terciopelo). Toxicon 23 (1985) 399-407
14. Beattie G.J., and Smyth J.F. Phase I study of intraperitoneal metalloproteinase inhibitor BB94 in patients with malignant ascites. Clin. Cancer Res. 8 (1998) 1899-1902
15. Bjarnason J.B., and Fox J.W. Hemorrhagic metalloproteinases from snake venoms. Pharmac. Ther 62 (1994) 325-372
16. Bode W., Gomis-Ruth F.X., and Stockler W. Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'. FEBS Lett. 331 (1993) 134-140
17. Bogarín G., Segura E., Durán G., Lomonte B., Rojas G., and Gutiérrez J.M. Evaluación de la capacidad de cuatro antivenenos comerciales para neutralizar el veneno de la serpiente Bothrops asper (terciopelo) de Costa Rica. Toxicon 33 (1995) 1242-1247
18. Bogarín G., Romero M., Rojas G., Lutsch C., Casadamont M., Lang J., Otero R., and Gutiérrez J.M. Neutralization, by a monospecific Bothrops lanceolatus antivenom, of toxic activities induced by homologus and heterologous Bothrops snake venoms. Toxicon 37 (1999) 551-557
19. Bogarín G., Morais J.F., Yamaguchi I.K., Stephano M.A., Marcelino J.R., Nishikawa A.K., Guidolin R., Rojas G., Higashi H.G., and Gutiérrez J.M. Neutralization of crotaline snake venoms from Central and South America by antivenoms produced in Brazil and Costa Rica. Toxicon 38 (2000) 1429-1441
20. Bon C. Serum therapy was discovered 100 years ago. In: Bon C., and Goyffon M. (Eds). Envenomings and their Treatments (1996), Fondation Marcel Mérieux, Lyon 3-9
21. 2. Comp. Biochem. Physiol. B 27 (2000) 21-30
22. Borges M.H., Soares A.M., Rodrigues V.M., Oliveira F., Fransheschi A.M., Rucavado A., Giglio J.R., and Homsi-Brandeburgo M.I. Neutralization of proteases from Bothrops snake venoms by the aqueous extract from Casearia sylvestris (Flacourtiaceae). Toxicon 39 (2001) 1863-1869
23. Borkow G., Gutiérrez J.M., and Ovadia M. Isolation and characterization of synergistic hemorrhagins from the venom of the snake Bothrops asper. Toxicon 31 (1993) 1137-1150
24. Borkow G., Gutiérrez J.M., and Ovadia M. A potent antihemorrhagin in the serum of the non-poisonous water snake Natrix tessellata: isolation, characterization and mechanism of neutralization. Biochim. Biophys. Acta 1201 (1994) 482-490
25. Borkow G., Gutiérrez J.M., and Ovadia M. Isolation, characterization and mode of neutralization of a potent antihemorrhagic factor from the serum of the snake Bothrops asper. Biochim. Biophys. Acta 1245 (1995) 232-238
26. Borkow G., Gutiérrez J.M., and Ovadia M. Inhibition of the hemorrhagic activity of Bothrops asper venom by a novel neutralizing mixture. Toxicon 35 (1997) 865-877
27. Borkow G., Gutiérrez J.M., and Ovadia M. Inhibition of toxic activities of Bothrops asper venom and other crotalid snake venoms by a novel neutralizing mixture. Toxicol. Appl. Pharmacol 147 (1997) 442-447
28. Botos I., Scapozza L., Zhang D., Liotta L.A., and Meyer E.F. Batimastat, a potent matrix metalloproteinase inhibitor, exhibits an unexpected mode of binding. Proc. Natl. Acad. Sci. USA 93 (1996) 2749-2754
29. Bottomley K.M., Johnson W.H., and Walter D.S. Matrix metalloproteinase inhibitors in arthritis. J. Enzyme Inhibition 13 (1998) 79-101
30. 2 from Bothrops asper snake venom. Archs. Biochem. Biophys 358 (1998) 343-350
31. Calderón L., and Lomonte B. Inhibition of the myotoxic action of Bothrops asper myotoxin II in mice by immunization with its synthetic peptide 115-129. Toxicon 37 (1999) 683-687
32. Cardoso J.L.C., Fan H.W., França F.O.S., Jorge M.T., Leite R.P., Nishioka S.A., Avila A., Sano-Martins I.S., Tomy S.C., Santoro M.L., Chudzinski A.M., Castro S.C.B., Kamiguti A.S., Kelen E.M.A., Hirata M.H., Mirandola R.M.S., Theakston R.D.G., and Warrell D.A. Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in São Paulo. Brazil. Quart. J. Med 86 (1993) 315-325
33. Castro O., Gutiérrez J.M., Barrios M., Castro I., Romero M., and Umaña E. Neutralización del efecto hemorrágico inducido por veneno de Bothrops asper (Serpentes: Viperidae) por extractos de plantas tropicales. Rev. Biol. Trop 47 (1999) 605-616
34. Cawston T.E. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol. Ther 70 (1996) 163-182
35. Cerdas L., and Lomonte B. Estudio de la capacidad ofiófaga y la resistencia de la zopilota (Clelia clelia, Colubridae) de Costa Rica a los venenos de serpiente. Toxicon 20 (1982) 936-939
36. Chan Y.S., Li Y., Foster W., Fu F.H., and Huard J. The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury. Am. J. Sports Med 33 (2005) 43-51
37. Chaves F., Gutiérrez J.M., and Brenes F. Pathological and biochemical changes induced in mice after intramuscular injection of venom from newborn specimens of the snake Bothrops asper (terciopelo). Toxicon 30 (1992) 1099-1109
38. Chaves F., Loría G.D., Salazar A., and Gutiérrez J.M. Intramuscular administration of antivenoms in experimental envenomation by Bothrops asper: comparison between Fab and IgG. Toxicon 41 (2003) 237-244
39. 2 by sequence analysis and site directed mutagenesis. Toxicon 42 (2003) 869-883
40. 2. Biochem. J. 366 (2002) 971-976
41. 2 by scanning alanine mutagenesis. Biochim. Biophys. Acta 1768 (2007) 1247-1257
42. Clark W.C., and Voris H.K. Venom neutralization by rattlesnake serum albumin. Science 164 (1969) 1402-1403
43. da Silva J.O., Coppede J.S., Fernandes V.C., Sant'Ana C.D., Ticli F.K., Mazzi M.V., Giglio J.R., Pereira P.S., Soares A.M., and Sampaio S.V. Antihemorrhagic, antinucleolytic and other antiophidian properties of the aqueous extract from Pentaclethra macroloba. J. Ethnopharmacol 100 (2005) 145-152
44. da Silva J.O., Fernandes R.S., Ticli F.K., Oliveira C.Z., Mazzi M.V., Franco J.J., Giuliatti S., Pereira P.S., Soares A.M., and Sampaio S.V. Triterpenoid saponins, new metalloprotease snake venom inhibitors isolated from Pentaclethra macroloba. Toxicon 50 (2007) 283-291
45. da Silva N.M.V., Arruda E.Z., Murakami Y.L.B., Moraes R.A.M., El-Kik C.Z., Tomaz M.A., Fernandes F.F.A., Oliveira C.Z., Soares A.M., Giglio J.R., and Melo P.A. Evaluation of three Brazilian antivenom ability to antagonize myonecrosis and hemorrhage induced by Bothrops snake venoms in a mouse model. Toxicon 50 (2007) 196-205
46. de Oliveira M., Cavalcante W.L.G., Arruda E.Z., Melo P.A., Silva M.D., and Gallacci M. Antagonism of myotoxic and paralyzing activities of bothropstoxin-I by suramin. Toxicon 42 (2003) 373-379
47. Deoras P.J., and Mhasalkar V.B. Antivenin activity of some snake sera. Toxicon 1 (1963) 89-90
48. Domont G.B., Perales J., and Moussatché H. Natural anti-snake venom proteins. Toxicon 29 (1991) 1183-1194
49. Eccles S., Box G.M., Court W.J., Bone E.A., Thomas W., and Brown P.D. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). Cancer Res. 56 (1996) 2815-2822
50. Escalante T., Franceschi A., Rucavado A., and Gutiérrez J.M. Effectiveness of batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper. Biochem. Pharmacol 60 (2000) 269-274
51. Estrada R., Robles A., Alvarado J., Rojas E., González N., Segura E., and Gutiérrez J.M. Development of antibody response and clinical and hematological alterations in horses immunized with snake venoms for the production of antivenom in Costa Rica. Mem. Inst. Butantan 53 (1991) 181-190
52. Fan H.W., and Cardoso J.L.C. Clinical toxicology of snakebites in South America. In: Meier J., and White J. (Eds). Handbook of Clinical Toxicology of Animal Venoms and Poisons (1995), CRC Press, Boca Ratón 667-688
53. Fernandes I., Takehara H.A., Santos A.C.R., Cormont F., Latinne D., Bazin H., and Mota I. Neutralization of bothropic and crotalic venom toxic activities by IgG(T) and IgGa subclasses isolated from immune horse serum. Toxicon 35 (1997) 931-936
54. Fernandes I., Lima E.X., Takehara H.A., Moura-da-Silva A.M., Tanjoni I., and Gutiérrez J.M. Horse IgG isotypes and cross-neutralization of two snake antivenoms produced in Brazil and Costa Rica. Toxicon 38 (2000) 633-644
55. Fernandes R.S., Assafim M., Arruda E.Z., Melo P.A., Zingali R.B., and Monteiro R.Q. Suramin counteracts the haemostatic disturbances produced by Bothrops jararaca snake venom. Toxicon 49 (2007) 931-938
56. 2 in the blood plasma of snakes. Toxicon 40 (2002) 481-484
57. 2 inhibitor from the plasma of the South American rattlesnake (Crotalus durissus terrificus). J. Biol. Chem. 269 (1994) 15646-15651
58. Gené J.A., Gómez M., Gutiérrez J.M., and Cerdas L. Neutralization of hyaluronidase and indirect hemolytic activities of Costa Rican snake venoms by a polyvalent antivenom. Toxicon 23 (1985) 1015-1018
59. Gené J.A., Roy A., Rojas G., Gutiérrez J.M., and Cerdas L. Comparative study on coagulant, defibrinating, fibrinolytic and fibrinogenolytic activities of Costa Rican crotaline snake venoms and their neutralization by a polyvalent antivenom. Toxicon 27 (1989) 841-848
60. Giavazzi R., Garofalo A., Ferri C., Lucchini V., Bone E.A., Chiari S., Brown P.D., Nicoletti M.I., and Taraboletti G. Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts. Clin. Cancer Res. 4 (1998) 985-992
61. Goucher C.R., and Flowers H.H. The chemical modification of necrogenic and proteolytic activities of venom and the use of EDTA to produce Agkistrodon piscivorous, a venom toxoid. Toxicon 2 (1964) 139-147
62. Gutiérrez J.M. Clinical toxicology of snakebite in Central America. In: Meier J., and White J. (Eds). Handbook of Clinical Toxicology of Animal Venoms and Poisons (1995), CRC Press, Boca Ratón 645-665
63. 2 myotoxins from Bothrops snake venoms. Toxicon 33 (1995) 1405-1424
64. 2 Enzymes: Structure, Function, and Mechanism (1997), John Wiley & Sons, England 321-352
65. Gutiérrez J.M., and Lomonte B. Efectos locales en el envenenamiento ofídico en América Latina. In: Costa Cardoso J.L., de Siqueira França F.O., Wen F.H., Sant'Ana Málaque C.M., and Haddad V. (Eds). Animais Peçonhentos no Brasil: biologia, clínica e terapêutica dos acidentes (2003), Sarvier Editora, São Paulo, Brasil 310-323
66. Gutiérrez J.M., Chaves F., and Bolaños R. Estudio comparativo de venenos de ejemplares recién nacidos y adultos de Bothrops asper. Rev. Biol. Trop 28 (1980) 341-351
67. Gutiérrez J.M., Arroyo O., and Bolaños R. Mionecrosis, hemorragia y edema inducidos por el veneno de Bothrops asper en ratón blanco. Toxicon 18 (1980) 603-610
68. Gutiérrez J.M., Chaves F., Bolaños R., Cerdas L., Rojas E., Arroyo O., and Portilla E. Neutralización de los efectos locales del veneno de Bothrops asper por un antiveneno polivalente. Toxicon 19 (1981) 493-500
69. Gutiérrez J.M., Ownby C.L., and Odell G.V. Isolation of a myotoxin from Bothrops asper venom: partial characterization and action on skeletal muscle. Toxicon 22 (1984) 115-128
70. Gutiérrez J.M., Gené J.A., Rojas G., and Cerdas L. Neutralization of proteolytic and hemorrhagic activities of Costa Rican snake venoms by a polyvalent antivenom. Toxicon 23 (1985) 887-893
71. Gutiérrez J.M., Rojas G., Lomonte B., Gené J., and Cerdas L. Comparative study of the edema-forming activity of Costa Rican snake venoms and its neutralization by a polyvalent antivenom. Comp. Biochem. Physiol 85C (1986) 171-175
72. Gutiérrez J.M., Chaves F., Rojas E., Elizondo J., Avila C., and Cerdas L. Production of monovalent anti- Bothrops asper antivenom: development of immune response in horses and neutralizing ability. Rev. Biol. Trop 36 (1988) 511-517
73. Gutiérrez J.M., Rojas G., Lomonte B., Gené J.A., Chaves F., Alvarado J., and Rojas E. Standardization of assays for testing the neutralizing ability of antivenoms (Letter). Toxicon 28 (1990) 1127-1129
74. Gutiérrez J.M., Romero M., Díaz C., Borkow G., and Ovadia M. Isolation and characterization of a metalloproteinase with weak hemorrhagic activity from the venom of the snake Bothrops asper (terciopelo). Toxicon 33 (1995) 19-29
75. Gutiérrez J.M., Romero M., Núñez J., Chaves F., Borkow G., and Ovadia M. Skeletal muscle necrosis and regeneration after injection of BaH1, a hemorrhagic metalloproteinase isolated from the venom of the snake Bothrops asper (terciopelo). Exp. Mol. Pathol 62 (1995) 28-41
76. Gutiérrez J.M., Rojas G., Bogarín G., and Lomonte B. Evaluation of the neutralizing ability of antivenoms for the treatment of snake bite envenoming in Central America. In: Bon C., and Goyffon M. (Eds). Envenomings and their Treatments (1996), Fondation Marcel Mérieux, Paris 223-231
77. Gutiérrez J.M., León G., Rojas G., Lomonte B., Rucavado A., and Chaves F. Neutralization of local tissue damage induced by Bothrops asper (terciopelo) snake venom. Toxicon 36 (1998) 1529-1538
78. Gutiérrez J.M., Rucavado A., and Ovadia M. Metalloproteinase inhibitors in snakebite envenomations. Drug Discovery Today 4 (1999) 532-533
79. Gutiérrez J.M., León G., and Lomonte B. Pharmacokinetic and pharmacodynamic relationships of immunoglobulin therapy for envenomation. Clin. Pharmacokin 42 (2003) 721-741
80. Gutiérrez, J.M., Theakston, R.D.G., Warrell, D.A., 2006. Confronting the neglected problem of snake bite envenoming: the need for a global partnership. PLoS Med. 3, e150. doi: 10.1371.
81. Gutiérrez J.M., Lomonte B., León G., Rucavado A., Chaves F., and Angulo Y. Trends in snakebite envenomation therapy: scientific, technological and public health considerations. Curr. Pharmac. Design 13 (2007) 2935-2950
82. 2s and haemorrhagins in neutralizing potential of antisera raised against Vipera ammodytes ammodytes venom. Comp. Biochem. Physiol. C 148 (2008) 178-183
83. Harvey A.L. Testing of natural remedies for natural toxins (Letter). Toxicon 41 (2003) 939
84. Ho M., Silamut K., White N.J., Karbwang J., Looareesuwan S., Phillips R.E., and Warrell D.A. Pharmacokinetics of three commercial antivenoms in patients envenomed by the Malayan pit viper, Calloselasma rhodostoma, in Thailand. Am. J. Trop. Med. Hyg 42 (1990) 260-266
85. Homma M., and Tu A.T. Antivenin for the treatment of local tissue damage due to envenomation by Southeast Asian snakes. Ineffectiveness in the prevention of local tissue damage in mice after envenomation. Am. J. Trop. Med. Hyg 19 (1970) 880-884
86. Howes J.M., Theakston R.D.G., and Laing G.D. Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators. Toxicon 49 (2007) 734-739
87. 2 inhibitor from the blood plasma of Trimeresurus flavoviridis. Sequence homologies with pulmonary surfactant apoprotein and animal lectins. J. Biol. Chem. 266 (1991) 1001-1007
88. 2 and Fab of the antivenin. Toxicon 36 (1998) 93-114
89. Jiménez-Porras J.M. Venom proteins of the fer-de-lance, Bothrops atrox, from Costa Rica. Toxicon 2 (1964) 155-166
90. 2 fragments of horse antivenom in the treatment of local symptoms after Cerastes cerastes (Egyptian snake) bite. African J. Biotechnol 2 (2003) 189-193
91. 2 polyvalent antivenoms do not differ in their ability to neutralize hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom. Toxicon 35 (1997) 1627-1637
92. 2EDTA of local tissue damage induced by Bothrops asper (terciopelo) venom: application in horse immunization for antivenom production. Toxicon 36 (1998) 321-331
93. 2 antivenoms to neutralize lethal and myotoxic effects induced by Micrurus nigrocinctus (coral snake) venom. Am. J. Trop. Med. Hyg 61 (1999) 266-271
94. León G., Valverde J.M., Rojas G., Lomonte B., and Gutiérrez J.M. Comparative study on the ability of IgG and Fab sheep antivenoms to neutralize local hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom. Toxicon 38 (2000) 233-244
95. 2 polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions. Toxicon 39 (2001) 793-801
96. Lin-Shiau S.Y., and Lin M.J. Suramin inhibits the toxic effects of presynaptic neurotoxins at the mouse motor nerve terminals. Eur. J. Pharmacol 382 (1999) 75-80
97. 2 myotoxin inhibitor from the plasma of the snake Bothrops asper. Biochem. J. 326 (1997) 853-859
98. 2 myotoxins from its own venom: isolation, molecular cloning, and biological properties. Biochem. J. 346 (2000) 631-639
99. 2 myotoxin inhibitor proteins from snakes, mammals and plants. Toxicon 42 (2003) 963-977
100. Lobo E.D., Hansen R.J., and Balthasar J.P. Antibody pharmacokinetics and pharmacodynamics. J. Pharm. Sci. 93 (2004) 2645-2668
101. Lomonte B. Edema-forming activity of bushmaster (Lachesis muta stenophrys) and Central American rattlesnake (Crotalus durissus durissus) venoms and neutralization by a polyvalent antivenom. Toxicon 23 (1985) 173-176
102. Lomonte B., and Carmona E. Individual expression patterns of myotoxin isoforms in the venom of the snake Bothrops asper. Comp. Biochem. Physiol 102B (1992) 325-329
103. Lomonte B., and Gutiérrez J.M. A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo). Toxicon 27 (1989) 725-733
104. Lomonte B., and Kahan L. Production and partial characterization of monoclonal antibodies to Bothrops asper (terciopelo) myotoxin. Toxicon 26 (1988) 675-689
105. Lomonte B., Cerdas L., Gené J.A., and Gutiérrez J.M. Neutralization of local effects of the Terciopelo (Bothrops asper) venom by blood serum of the colubrid snake Clelia clelia. Toxicon 20 (1982) 571-579
106. Lomonte B., Gutiérrez J.M., and Mata E. Isolation from a polyvalent antivenom of antibodies to a myotoxin in Bothrops asper snake venom. Toxicon 23 (1985) 807-813
107. Lomonte B., Gutiérrez J.M., Moreno E., and Cerdas L. Antibody neutralization of a myotoxin from the venom of Bothrops asper (Terciopelo). Toxicon 25 (1987) 443-449
108. Lomonte B., Moreno E., and Gutiérrez J.M. Detection of proteins antigenically-related to Bothrops asper myotoxin in crotaline snake venoms. Toxicon 25 (1987) 947-955
109. Lomonte B., Cerdas L., Solórzano A., and Martínez S. El suero de neonatos de Clelia clelia (Serpentes: Colubridae) neutraliza la acción hemorrágica del veneno de Bothrops asper (Serpentes: Viperidae). Rev. Biol. Trop 38 (1989) 325-326
110. Lomonte B., Gutiérrez J.M., Carmona E., and Rovira M.E. Equine antibodies to Bothrops asper myotoxin II: isolation from polyvalent antivenom and neutralizing ability. Toxicon 28 (1990) 379-384
111. Lomonte B., Furtado M.F., Rovira M.E., Carmona E., Rojas G., Aymerich R., and Gutiérrez J.M. South American snake venom proteins antigenically-related to Bothrops asper myotoxins. Braz. J. Med. Biol. Res. 23 (1990) 427-435
112. Lomonte B., Gutiérrez J.M., Rojas G., and Calderón L. Quantitation by enzyme-immunoassay of antibodies against Bothrops myotoxins in four commercially-available antivenoms. Toxicon 29 (1991) 695-702
113. 2 from the venom of the snake Bothrops asper by monoclonal antibodies. Toxicon 30 (1992) 239-245
114. Lomonte B., Lundgren J., Johansson B., and Bagge U. The dynamics of local tissue damage induced by Bothrops asper snake venom and myotoxin II on the mouse cremaster muscle: an intravital and electron microscopic study. Toxicon 32 (1994) 41-55
115. 2 from Bothrops asper snake venom by glycosaminoglycans of the heparin/heparan sulfate family. Biochem. Pharmacol 47 (1994) 1509-1518
116. 2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling. J. Biol. Chem. 269 (1994) 29867-29873
117. 2 antivenoms in the neutralization of hemorrhagic activity of Vipera berus snake venom in mice. Toxicon 34 (1996) 1197-1202
118. 2 expresses enhanced membrane-damaging activities and reproduces its in vivo myotoxic effect. Biochim. Biophys. Acta 1461 (1999) 19-26
119. 2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action. Toxicon 42 (2003) 885-901
120. 2 from snake venoms. Toxicon 42 (2003) 307-312
121. Melo P.A., and Suarez-Kurtz G. Release of sarcoplasmic enzymes from skeletal muscle by Bothrops jararacussu venom: antagonism by heparin and by the serum of South American marsupials. Toxicon 26 (1988) 87-95
122. Melo P.A., Homsi-Brandeburgo M.I., Giglio J.R., and Suarez-Kurtz G. Antagonism of the myotoxic effect of Bothrops jararacussu venom and bothropstoxin by polyanions. Toxicon 31 (1993) 285-291
123. 2 fragments. Toxicon 32 (1994) 725-734
124. Moreira L., Borkow G., Ovadia M., and Gutiérrez J.M. Pathological changes induced by BaH1, a hemorrhagic metalloproteinase isolated from Bothrops asper (terciopelo) snake venom, on mouse capillary blood vessels. Toxicon 32 (1994) 977-987
125. 2 variants: identification of isozymes in the venoms of newborn and adult Bothrops asper (terciopelo) snakes. Toxicon 26 (1988) 363-371
126. Moura-da-Silva A.M., Cardoso D.F., Tanizaki M.M., and Mota I. Neutralization of myotoxic activity of Bothrops venoms by antisera to purified myotoxins and to crude venoms. Toxicon 29 (1991) 1471-1480
127. Murakami M.T., Arruda E.Z., Melo P.A., Martinez A.B., Lomonte B., Gutiérrez J.M., and Arni R.K. Inhibition of myotoxic activity of Bothrops asper myotoxin II by the anti-trypanosomal drug suramin. J. Mol. Biol. 350 (2005) 416-426
128. Neves-Ferreira A.G., Perales J., Ovadia M., Moussatche H., and Domont G. Inhibitory properties of the antibothropic complex from the South American opossum (Didelphis marsupialis) serum. Toxicon 35 (1997) 849-863
129. Neves-Ferreira A.G., Perales J., Fox J.W., Shannon J.D., Makino D.L., Garratt R.C., and Domont G.B. Structural and functional analyses of DM43, a snake venom metalloproteinase inhibitor from Didelphis marsupialis serum. J. Biol. Chem. 277 (2002) 13129-13137
130. Nishioka S.A., and Silveira P.V.P. A clinical and epidemiologic study of 292 cases of lance-headed viper bite in a Brazilian teaching hospital. Am. J. Trop. Med. Hyg 47 (1992) 805-810
131. 2 from Agkistrodon piscivorus piscivorus snake venom: synthetic C-terminal peptides from Lys49, but not from Asp49 myotoxins, exert membrane-damaging activities. Toxicon 39 (2001) 1587-1594
132. Núñez V., Otero R., Barona J., Saldarriaga M., Osorio R.G., Fonnegra R., Jiménez S.L., Díaz A., and Quintana J.C. Neutralization of the edema-forming, defibrinating and coagulant effects of Bothrops asper venom by extracts of plants used by healers in Colombia. Braz. J. Med. Biol. Res. 37 (2004) 969-977
133. 2 from Bothrops snake venoms: isolation of 4-nerolidylcatechol as active principle. Phytochemistry 66 (2005) 1017-1025
134. 2 inhibitors from the blood plasma of the Chinese mamushi, Agkistrodon blomhoffi siniticus. Biochem. J. 325 (1997) 527-531
135. Ohsaka A. Hemorrhagic, necrotizing and edema-forming effects of snake venoms. In: Lee C.Y. (Ed). Handbook of Experimental Pharmacology vol. 52 (1979), Snake Venoms. Springer-Verlag, Berlin 480-546
136. 2 inhibitor from Bothrops jararacussu snake plasma: structural and functional characterization. Biochimie 90 (2008) 1506-1514
137. Otero R., Nuñez V., Osorio R.G., Gutiérrez J.M., Giraldo C.A., and Posada L.E. Ability of six Latin American antivenoms to neutralize the venom of Mapaná equis (Bothrops atrox) from Antioquía and Chocó (Colombia). Toxicon 33 (1995) 809-815
138. Otero R., Gutiérrez J.M., Núñez V., Robles A., Estrada R., Segura E., Toro M.F., García, Díaz A., M.E, Ramírez E.C., Gómez C., Castañeda J., Moreno M.E., and the regional group on antivenom therapy (REGATHER). A randomized
139. Otero-Patiño R., Cardoso J.L.C., Higashi H.G., Nunez V., Diaz A., Toro M.F., Garcia M.E., Sierra A., Garcia L.F., Moreno A.M., Medina M.C., Castañeda N., Silva-Diaz J.F., Murcia M., Cardenas S.Y., da Silva W.D.D., and the regional group on antivenom therapy (REGATHER). A randomized, blinded, comparative trial of one pepsin-digested and two whole IgG antivenoms for Bothrops snake bites in Uraba, Colombia. Am. J. Trop. Med. Hyg 58 (1998) 183-189
140. Otero R., Gutiérrez J.M., Rojas G., Núñez V., Díaz A., Miranda E., Uribe A.F., Silva J.F., Ospina J.G., Medina Y., Toro M.F., García M.E., León G., García M., Lizano S., and the regional groups in antivenom therapy research (REGATHER). A randomized blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG, in Bothrops and Porthidium snake bites in Colombia. Correlation between safety and biochemical characteristics of antivenoms. Toxicon 37 (1999) 895-908
141. Otero R., Núñez V., Jiménez S.L., Fonnegra R., Osorio R.G., García M.E., and Díaz A. Snakebites and ethnobotany in the northwest region of Colombia. Part II: neutralization of lethal and enzymatic effects of Bothrops atrox venom. J. Ethnopharmacol 71 (2000) 505-511
142. Otero R., Núñez V., Barona J., Fonnegra R., Jiménez S.L., Osorio R.G., Saldarriaga M., and Díaz A. Snakebites and ethnobotany in the northwest region of Colombia. Part III: Neutralization of lethal and enzymatic effects of Bothrops atrox venom. J. Ethnopharmacol 73 (2000) 233-241
143. Otero R., Núñez V., Barona J., Díaz A., and Saldarriaga M. Características bioquímicas y capacidad neutralizante de cuatro antivenenos polivalentes frente a los efectos farmacológicos y enzimáticos del veneno de Bothrops asper y Porthidium nasutum de Antioquia y Chocó. Iatreia 15 (2002) 5-15
144. Otero R., Gutiérrez J., Mesa M.B., Duque E., Rodríguez O., Arango J.L., Gómez F., Toro A., Cano F., Rodríguez L.M., Caro E., Martínez J., Cornejo W., Gómez L.M., Uribe F.L., Cárdenas S., Núñez V., and Díaz A. Complications of Bothrops, Porthidium and Bothriechis snakebites in Colombia. A clinical and epidemiological study of 39 cases attended in a university hospital. Toxicon 40 (2002) 1107-1114
145. Otero R., León G., Gutiérrez J.M., Rojas G., Toro M.F., Barona J., Rodríguez V., Díaz A., Núñez V., Quintana J.C., Ayala S., Mosequera D., Conrado L.L., Fernández D., Arroyo Y., Paniagua C.A., López M., Ospina C.E., Alzate C., Fernández J., Meza J.J., Silva J.F., Ramírez P., Fabra P.E., Ramírez E., Córdoba E., Arrieta A.B., Warrell D.A., and Theakston R.D.G. Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without β-propiolactone, in the treatment of Bothrops asper bites in Colombia. Trans. Royal Soc. Trop. Med. Hyg 100 (2006) 1173-1182
146. ®, un antiveneno polivalente producido en México. Iatreia 20 (2007) 244-262
147. Ovadia M. Purification and characterization of an anti-hemorrhagic factor from the serum of the snake Vipera palaestinae. Toxicon 16 (1978) 661-672
148. Ovadia M., and Kochva E. Neutralization of Viperidae and Elapidae snake venoms by sera of different animals. Toxicon 15 (1977) 541-547
149. Ownby C.L., Kainer R.A., and Tu A.T. Pathogenesis of hemorrhage induced by rattlesnake venom. Am. J. Pathol 76 (1974) 401-414
150. Ownby C.L., Tu A.T., and Kainer R.A. Effect of diethylenetriaminepentaacetic acid and procaine on hemorrhage induced by rattlesnake venom. J. Clin. Pharmacol 15 (1975) 419-425
151. Ownby C.L., Odell G.V., Woods W.M., and Colberg T.R. Ability of antiserum to myotoxin a from prairie rattlesnake (Crotalus viridis viridis) venom to neutralize local myotoxicity and lethal effects of myotoxin a and homologous crude venom. Toxicon 21 (1983) 35-45
152. Ownby C.L., Colberg T.R., Claypool P.L., and Odell G.V. In vivo test of the ability of antiserum to myotoxin a from prairie rattlesnake (Crotalus viridis viridis) venom to neutralize local myonecrosis induced by myotoxin a and homologous crude venom. Toxicon 22 (1984) 99-105
153. Ownby C.L., Colberg T.R., and Odell G.V. In vivo ability of antimyotoxin a serum plus polyvalent (Crotalidae) antivenom to neutralize prairie rattlesnake (Crotalus viridis viridis) venom. Toxicon 24 (1986) 197-200
154. 2 from Bothrops asper snake venom: synthetic Lys49 myotoxin II-(115-129)-peptide identifies its bactericidal region. Eur. J. Biochem 253 (1998) 452-461
155. Pardal P.P.O., Souza S.M., Monteiro M.R.C.C., Fan H.W., Cardoso J.L.C., França F.O.S., Tomy S.C., Sano_martins I.S., Sousa-e-Silva M.C.C., Colombini M., Kodera N.F., Moura-da-Silva A.M., Cardoso D.F., Velarde D.T., Kamiguti A.S., Theakston R.D.G., and Warrell D.A. Clinical trial of two antivenoms for the treatment of Bothrops and Lachesis bites in the north eastern Amazon region of Brazil. Trans. Royal Soc. Trop. Med. Hyg 98 (2004) 28-42
156. Patankar M., Oehninger S., Barnett T., Williams R., and Clark G. A revised structure for fucoidan may explain some of its biological activities. J. Biol. Chem. 268 (1993) 21770-21776
157. 2 antivenom from hyperimmunized horse: pharmacokinetics following intravenous and intramuscular administrations in rabbits. Pharm. Res. 12 (1995) 1470-1473
158. 2-scorpion venom interactions. Toxicol. Appl. Pharmacol 141 (1996) 272-277
159. Perales J., Villela C., Domont G.B., Choumet V., Saliou B., Moussatche H., Bon C., and Faure G. Molecular structure and mechanism of action of the crotoxin inhibitor from Crotalus durissus terrificus serum. Eur. J. Biochem 227 (1995) 19-26
160. Perales J., Neves-Ferreira A.G., Valente R.H., and Domont G. Natural inhibitors of snake venom hemorrhagic metalloproteinases. Toxicon 45 (2005) 1013-1020
161. Pereañez J.A., Jiménez S., Quintana J.C., Núñez V., Fernández M., and Restrepo Y. Inhibición de las actividades proteolítica, coagulante y hemolítica indirecta inducidas por el veneno de Bothrops asper por extractos etanólicos de tres especies de Heliconias. Vitae 15 (2008) 157-164
162. Pérez J.C., and Sánchez E.E. Natural protease inhibitors to hemorrhagins in snake venoms and their potential use in medicine. Toxicon 37 (1999) 703-728
163. Perez J.C., Haws W.C., Garcia V.E., and Jennings B.M. Resistance of warm-blooded animals to snake venoms. Toxicon 16 (1978) 375-383
164. Picado, C., 1931. Serpientes venenosas de Costa Rica. Editorial Costa Rica, 154 pp.
165. Picolo G., Chacur M., Gutiérrez J.M., Teixeira C.F.P., and Cury Y. Evaluation of antivenoms in the neutralization of hyperalgesia and edema induced by Bothrops jararaca and Bothrops asper snake venoms. Braz. J. Med. Biol. Res. 35 (2002) 1221-1228
166. Queiroz L.S., Santo Neto H., Rodrigues-Simioni L., and Prado-Franceschi J. Muscle necrosis and regeneration after envenomation by Bothrops jararacussu snake venom. Toxicon 22 (1984) 339-346
167. Quesada L., Sevcik C., Lomonte B., Rojas E., and Gutiérrez J.M. Pharmacokinetics of whole IgG equine antivenom: comparison between normal and envenomated rabbits. Toxicon 48 (2006) 255-263
168. 2 myotoxin inhibitor from the plasma of the snake Atropoides nummifer (Viperidae: Crotalinae). Comp. Biochem. Physiol. B 146 (2007) 60-68
169. ® Africa) against African vipers and elapids. Toxicon 52 (2008) 881-888
170. Reyes-Chilpa R., Gómez-Garibay F., Quijano L., Magos-Guerrero G.A., and Ríos T. Preliminary results on the protective effect of (-)-edunol, a pterocarpan from Brongniartia podalyrioides (Leguminosae), against Bothrops atrox venom in mice. J. Ethnopharmacol 42 (1994) 199-203
171. Richardson W.H., Tanen D.A., Tong T.C., Betten D.P., Carstairs S.D., Williams S.R., Cantrell F.L., and Clark R.F. Crotalidae polyvalent immune Fab (ovine) antivenom is effective in the neutralization of South American Viperidae venoms in a murine model. Ann. Emerg. Med 45 (2005) 595-602
172. Rocha S.L.G., Lomonte B., Neves-Ferreira A.G., Trugilho M.R.O., Junqueira-de-Azevedo I.L.M., Ho P.L., Domont G., Gutiérrez J.M., and Perales J. Functional analysis of DM64, an antimyotoxic protein with immunoglobulin-like structure from Didelphis marsupialis serum. Eur. J. Biochem 269 (2002) 6052-6062
173. Rojas G., Gutiérrez J.M., Gené J.A., Gómez M., and Cerdas L. Neutralización de las actividades tóxicas y enzimáticas de cuatro venenos de serpientes de Guatemala y Honduras por el antiveneno polivalente producido en Costa Rica. Rev. Biol. Trop 35 (1987) 59-67
174. Rojas G., Espinoza M., Lomonte B., and Gutiérrez J.M. Effect of storage temperature on the stability of polyvalent antivenom produced in Costa Rica. Toxicon 28 (1990) 101-105
175. Rojas G., Jiménez J.M., and Gutiérrez J.M. Caprylic acid fractionation of hyperimmune horse plasma: description of a simple procedure for antivenom production. Toxicon 32 (1994) 351-363
176. Rojas E., Quesada L., Arce V., Lomonte B., Rojas G., and Gutiérrez J.M. Neutralization of four Peruvian Bothrops sp. snake venoms by polyvalent antivenoms produced in Perú and Costa Rica: preclinical assessment. Acta Tropica 93 (2005) 85-95
177. Rucavado A., and Lomonte B. Neutralization of myonecrosis, hemorrhage, and edema induced by Bothrops asper snake venom by homologous and heterologous pre-existing antibodies in mice. Toxicon 34 (1996) 567-577
178. Rucavado A., Borkow G., Ovadia M., and Gutiérrez J.M. Immunological studies on BaH1 and BaP1, two hemorrhagic metalloproteinases from the venom of the snake Bothrops asper. Toxicon 33 (1995) 1103-1106
179. Rucavado A., Lomonte B., Ovadia M., and Gutiérrez J.M. Local tissue damage induced by BaP1, a metalloproteinase isolated from Bothrops asper (terciopelo) snake venom. Exp. Mol. Pathol 63 (1995) 186-199
180. Rucavado A., Núñez J., and Gutiérrez J.M. Blister formation and skin damage induced by BaP1, a haemorrhagic metalloproteinase from the venom of the snake Bothrops asper. Int. J. Exp. Pathol 79 (1998) 245-254
181. 2EDTA. Am. J. Trop. Med. Hyg 63 (2000) 313-319
182. Rucavado A., Escalante T., and Gutiérrez J.M. Effect of the metalloproteinase inhibitor batimastat in the systemic toxicity induced by Bothrops asper snake venom: understanding the role of metalloproteinases in envenomation. Toxicon 43 (2004) 417-424
183. Rucavado A., Soto M., Escalante T., Loría G.D., Arni R., and Gutiérrez J.M. Thrombocytopenia and platelet hypoaggregation induced by Bothrops asper snake venom: toxins involved and their contribution to metalloproteinase-induced pulmonary hemorrhage. Thromb. Haemost 94 (2005) 123-131
184. Rucavado A., Henríquez M., García J., and Gutiérrez J.M. Assessment of metalloproteinase inhibitors clodronate and doxycycline in the neutralization of hemorrhage and coagulopathy induced by Bothrops asper snake venom. Toxicon 52 (2008) 754-759
185. Russell F.E., Ruzic N., and Gonzalez H. Effectiveness of antivenin (Crotalidae) polyvalent following injection of Crotalus venom. Toxicon 11 (1973) 461-464
186. Saborío P., González M., and Cambronero M. Accidente ofídico en niños en Costa Rica: epidemiología y detección de factores de riesgo en el desarrollo de absceso y necrosis. Toxicon 36 (1998) 359-366
187. Saldarriaga M.M., Otero R., Núñez V., Toro M.F., Díaz A., and Gutiérrez J.M. Ontogenetic variability of Bothrops atrox and Bothrops asper venoms from Colombia. Toxicon 42 (2003) 405-411
188. Sánchez E.E., Ramírez M.S., Galán J.A., López G., Rodríguez A., and Perez J. Cross reactivity of three antivenoms against North American snake venoms. Toxicon 41 (2003) 315-320
189. Saravia P., Rojas E., Escalante T., Arce V., Chaves E., Velásquez R., Lomonte B., Rojas G., and Gutiérrez J.M. The venom of Bothrops asper from Guatemala: toxic activities and neutralization by antivenoms. Toxicon 39 (2001) 401-405
190. Sawai Y., Makino M., Miyasaki S., Kawamura Y., Mitsuhashi S., and Okonogi T. Studies on the improvement of treatment of Habu snake (Trimeresurus flavoviridis) bite. Antitoxic action of monocalcium disodium ethylene diamine tetraacetate on Habu venom. Jap. J. Exp. Med 31 (1961) 267-275
191. Skiles J.W., Gonnella N.C., and Jeng A.Y. The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors. Curr. Med. Chem. 11 (2004) 2911-2977
192. Smalligan R., Cole J., Brito N., Laing G.D., Mertz B.L., Manock S., Maudlin J., Quist B., Holland G., Nelson S., Lalloo D.G., Rivadeneira G., Barragan M.E., Dolley D., Eddleston M., Warrell D.A., and Theakston R.D.G. Crotaline snake bite in the Ecuadorian Amazon: randomised double blind comparative trial of three South American polyspecific antivenoms. Br. Med. J. 329 (2004) 1129-1136
193. 2 myotoxin inhibitor protein from Bothrops moojeni snake plasma. Biochem. Biophys. Res. Comm 302 (2003) 193-200
194. Soares A.M., Ticli F.K., Marcussi S., Lourenço M.V., Januário A.H., Sampaio S.V., Giglio J.R., Lomonte B., and Pereira P.S. Medicinal plants with inhibitory properties against snake venoms. Curr. Med. Chem. 12 (2005) 2625-2641
195. Solórzano, A., 2004. Serpientes de Costa Rica. San José, Editorial InBio, 792 pp.
196. Šribar J., Kovačič L., Draškovič P., Faure G., and Križaj I. The first phospholipase inhibitor from the serum of Vipera ammodytes ammodytes. FEBS J. 274 (2007) 6055-6064
197. Steinbach F., Deeg C., Mauel S., and Wagner B. Equine immunology: offspring of the serum horse. Trends Immunol 23 (2002) 223-225
198. Tan N.H., and Ponnudurai G. A comparative study of the biological properties of some venoms of snakes of the genus Bothrops (American lance-headed vipers). Comp. Biochem. Physiol. B 100 (1991) 361-365
199. Theakston R.D.G., Warrell D.A., and Griffiths E. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon 41 (2003) 541-557
200. Thwin M.M., and Gopalakrishnakone P. Snake envenomation and protective natural endogenous proteins: a mini review of the recent developments (1991-1997). Toxicon 36 (1998) 1471-1482
201. 2 inhibition and venom neutralizing potential. Biochemistry 39 (2000) 9604-9611
202. 2 inhibitor from python serum. Eur. J. Biochem 269 (2002) 719-727
203. Trento E.P., Garcia O.S., Rucavado A., França S.C., Batalini C., Arantes E.C., Giglio J.R., and Soares A.M. Inhibitory properties of the anti-bothropic complex from Didelphis albiventris serum on toxic and pharmacological actions of metalloproteases and myotoxins from Bothrops asper venom. Biochem. Pharmacol 62 (2001) 1521-1529
204. Tu A.T., Homma M., and Hong B.S. Hemorrhagic, myonecrotic, thrombotic and proteolytic activities of viper venoms. Toxicon 6 (1969) 175-178
205. Tu G., Xu W., Huang H., and Li S. Progress in the development of matrix metalloproteinase inhibitors. Curr. Med. Chem. 15 (2008) 1388-1395
206. 2: clues towards identification of residues involved in a novel mechanism of membrane damage and in myotoxicity. Prot. Engin 11 (1998) 285-294
207. Warrell D.A. Clinical features of envenoming by snake bites. In: Bon C., and Goyffon M. (Eds). Envenomings and Their Treatments (1996), Fondation Marcel Mérieux, Lyon 63-76
208. Williamson J., and Desowitz R.S. Prophylactic activity of suramin complexes in animal trypanosomiasis. Nature 177 (1956) 1074-1075
209. Zhou X., Tan T.C., Valiyaveettil S., Go M.L., Kini R.M., Velazquez-Campoy A., and Sivaraman J. Structural characterization of myotoxic ecarpholin S from Echis carinatus venom. Biophys. J. 95 (2008) 3366-3380